References

1. Gujral N, Freeman HJ, Thomson AB. Celiac disease: prevalence, diagnosis, pathogenesis and treatment. World J Gastroenterol. 2012 Nov 14; 18(42): 6036-59. PubMed | Google Scholar


2. Kaushal K, Prasad, Uma Debi, Saroj K, Sinha, Chander K, Nain, Kartar Singh. "Hepatobiliary Disorders in Celiac Disease: an update." International Journal of Hepatology. 2011; 2011: 438184. PubMed | Google Scholar


3. Dyson JK, Anstee QM, McPherson S. Non-alcoholic fatty liver disease: a practical approach to treatment. Frontline Gastroenterology. 2014; 5(4): 277-286. PubMed | Google Scholar


4. Tasneem AA, Luck NH, Majid Z. Factors predicting non-alcoholic steatohepatitis (NASH) and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD). Trop Doct. 2018 Apr; 48(2): 107-112. PubMed | Google Scholar


5. Anania C, De Luca E, De Castro G, Chiesa C, Pacifico L. Liver involvement in pediatric celiac disease. World J Gastroenterol. 2015 May 21; 21(19): 5813-22. PubMed | Google Scholar


6. Reilly NR, Lebwohl B, Hultcrantz R, Green PH, Ludvigsson JF. Increased risk of non-alcoholic fatty liver disease after diagnosis of celiac disease. J Hepatol. 2015 Jun; 62(6): 1405-11. PubMed | Google Scholar


7. Rubio-Tapia A, Murray JA. Liver involvement in celiac disease. Minerva Med. 2008 Dec; 99(6): 595-604. PubMed | Google Scholar